Hamburg, Germany
Velocity Clinical Research Germany GmbH
Founded in 2004 as Clinical Research Hamburg GmbH and acquired by Velocity Clinical Research in 2022, the experienced team at Velocity’s dedicated research site in Hamburg conducts Phase 2-4 clinical trials across a broad variety of indications. The site partners with specialists in dermatology, orthopedics, gynecology, internal medicine, and general medicine. By developing strong working relationships with local communities and having close ties with networks of cooperating practices, Velocity’s Hamburg staff provides fast, accurate patient enrollment support, even for diverse populations.
Our Hamburg team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research. With decades of research experience shared among our investigators in Hamburg, Velocity will deliver the right patients, investigators, and research staff for your next research program.
Velocity Clinical Research Germany GmbH
Spitalerstraße 4, 4. OG, 20095 Hamburg, Germany
Phone: +49 40 6312970
Find a Clinical Trial in Hamburg
Visit VelocityClinicalTrials.de for study updates and more.
Our experienced research team in Hamburg
The Velocity Hamburg team of physician investigators and clinical research professionals are experienced clinical researchers. All physicians are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Training records and certifications are maintained. Our clinical team is dedicated to conducting quality research in a professional and caring environment and strives on collecting quality data.
-
Medical Director, Principal Investigator
With over 20 years of experience in clinical research, Dr. Jambrecina specializes in early-phase clinical trials and the conduct of complex studies. After completing his medical degree in 2001 at the University Medical Center Hamburg-Eppendorf, he assumed, among other roles, several leadership positions at the Clinical Trial Center North located at the University Medical Center Hamburg-Eppendorf.
In addition, he has gained extensive experience in vaccine research as well as in clinical development in the fields of infectious diseases and cardiometabolic disorders. Since 2023, Dr. Jambrecina has been serving as Medical Director and Principal Investigator at the Velocity Hamburg site.
-
Principal Investigator
Anastasia Kelidou is an experienced clinical researcher with over 15 years of expertise in the conduct of Phase I–IV clinical trials.
She has worked across a broad range of therapeutic areas, including internal medicine, cardiology, neurology, and vaccines.
Anastasia earned her medical degree and licensure from the University Medical Center Hamburg-Eppendorf. Her background includes leadership roles as Head Investigator and Head of Clinical Operations, ensuring high-quality study execution and regulatory compliance. -
Site Director
Jasmin is a clinical research leader with over ten years of experience, combining a strong background as a Medical Assistant and Biological Technical Assistant with extensive expertise in clinical trial management. In her role as Site Director, she brings comprehensive experience in the conduct and oversight of complex Phase I through Phase IV clinical trials. Her primary focus lies in pharmacokinetic (PK) studies and trials involving advanced laboratory procedures, including PCR analysis, PBMC processing, and investigational product preparation (reconstitution). She is particularly committed to maintaining operational excellence and ensuring strict adherence to regulatory standards.Prior to this role, Jasmin worked at the Clinical Trial Center North at the University Medical Center Hamburg-Eppendorf, where she held leadership positions as Head of Clinical Study Management and Head Study Nurse. In these roles, she significantly contributed to the successful execution of clinical trials while further strengthening her expertise and leadership capabilities over several years. Through her combined clinical and strategic leadership experience, Jasmin is dedicated to ensuring the highest standards of quality in clinical research, fostering high-performing teams, and advancing innovative therapeutic approaches.
Hamburg facility features
The Velocity Clinical Research Germany GmbH facility is designed for the ease and comfort of study participants and to allow optimal efficiencies in performing clinical trials. Features at this site include:
- Private examination/consultation rooms
- Comfortable patient reception areas
- Facilities for extended-stay pharmacokinetic studies
- Parking
- Nursing station
- Secure monitoring rooms or workstations with phone & high-speed internet access
- Multiple individual & secure workstations for research staff
- Regulatory document processing area
- Electronic data capture (EDC) capabilities
- Secure record storage
- CLIA certified research laboratory or clinical laboratory with CLIA waiver
- Ambient and refrigerated centrifuge
- Secured & temperature controlled investigational product storage with pharmaceutical refrigerator & freezer
- Freezers equipped for laboratory specimens at -20 & -70 degrees Celsius
- Backup generator/power source in the event of site power loss
- Standard medical equipment, including ECG and Holter machines, digital and analog scales
